Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of DS-5058b to oxycodone in healthy Japanese subjects
jRCT1080223420Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of oxycodone in pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Cmax bioequivalence and AUCt bioequivalence. Started Dec 2016; status: completed.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on jRCT1080223420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223420.